Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis

International Journal of Dermatology

Volumn 36, Issue 2, 1997, Pages 116-122

  Ohtsuka, Tsutomu ^a   Hasegawa, Akira ^b   Nakano, Akihiko ^b   Yamakage, Akio ^b   Yamaguchi, Mary ^b   Miyachi, Yoshiki ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MICROSCOPY; NAIL DISEASE; PULMONARY HYPERTENSION; SKIN CAPILLARY; SYSTEMIC SCLEROSIS;

EID: 0030980128     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00088.x     Document Type: Article

References (30)

1. Masi AT, D'Angelo WA. Epidemiology of fatal systemic sclerosis (diffuse scleroderma). Ann Intern Med 1967; 66: 870-883.
2. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple classification in the early stages of the disease. J Rheumatol 1988; 15: 276-283.
3. Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1987; 64: 998-1004.
4. Maricq HR, Spencer-Green G, LeRoy EC. Skin capillary abnormalities as an indicator of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862-870.
5. Lee P, Leung FY-K, Alderdice C, Armstrong SK. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983; 10: 930-938.
6. Schmidt K-U, Mensing H. Are nailfold capillary changes indicators of organ involvement in progressive systemic sclerosis? Dermatologica 1988; 176: 18-21.
7. Groen H, Wichers G, Borg EJ, et al. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease. Am J Med 1990; 89: 34-41.
8. Houtman PM, Kallenberg CGM, Wounda AA, The TH. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis 1985; 44: 603-609.
9. Lovy M, MacCarter D, Steigerwald JC. Relation between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985; 28: 496-501.
10. Lefford F, Edwards JCW. Nailfold capillary microscopy in connective tissue diseases: a quantitative morphological analysis. Ann Rheum Dis 1986; 45: 741-749.
11. Statham BN, Rowell NR. Quantification of the nail fold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockh) 1986; 66: 139-143.
12. Ohtsuka T, Ishikawa H. Statistical definition of nailfold capillary pattern in patients with systemic sclerosis. Dermatology 1994; 188: 286-289.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association, Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
14. Sharp CG, Irvin WS, Tan EM, et al. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1971; 52: 148-159.
15. Ungerer RG, Tashkin DP, Clements PJ, et al. Prevalence and clinical correlates of pulmonary hypertension in progressive systemic sclerosis. Am J Med 1983; 75: 65-74.
16. LeRoy EC, Krieg T, Black C, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15: 202-205.
17. Bout SG Jr, Grover RF. In: Hurst JW, ed. The Heart, 4th edn. New York: MacGraw-Hill, 1978: 1456-1472.
18. Chang CH. The normal roentgenographic measurement of the right descending pulmonary artery in 1085 cases. Am J Radiol 1962; 87: 929-935.
19. Marriot HJ. Practical Electrocardiography, 6th edn. Baltimore: Williams and Wilkins, 1987: 294-295.
20. Smith JW, Clements PJ, Levisman J, et al. Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with hemodynamic and postmortem studies. Am J Med 1979; 66: 28-33.
21. Ohtsuka T, Yamakage A, Miyachi Y. Statistical definition of nailfold capillary pattern in patients with psoriasis. Int J Dermatol 1994; 33: 779-782.
22. Kendall M. Multivariate Analysis, 2nd edn. High Wycombe, England: Charles Griffin & Co, 1980.
23. Maricq HR. Widefield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981; 24: 1159-1165.
24. Steen VD, Powell DL, Medsger T Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 131: 196-203.
25. Sackner MA, Akgun N, Kinbel P, Lewis D. The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med 1964; 60: 611-630.
26. Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-524.
27. Owens GR, Fino GJ, Herbert DL, et al. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 1983; 84: 546-550.
28. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970; 73: 317-324.
29. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144: 706-713.
30. Kahaleh M, Sherer G, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979; 149: 1326-1335.